MedTrace Logo

A Provocation Study Using Biogenic Amines to Show the Efficacy of Oral Diamine Oxidase Supplementation

NCT02418221 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2015-04-16

No results posted yet for this study

Summary

This study aims to define a provocation test for histamine intolerance (aka. biogenic amine intolerance syndrome) and test the capability of an oral enzyme supplementation to ameliorate this condition.

Conditions

  • Histamine Intolerance

Interventions

DIETARY_SUPPLEMENT

DAOSiN®/ Placebo & ProvokAmin® Ingestion

Proband is randomly assigned Daosin® or the Placebo before provocation with ProvokAmin®

PROCEDURE

Drawing blood, measuring BP & pulse

Taking of a blood sample and recording of blood pressure \& pulse

Sponsors & Collaborators

  • Medical University of Graz

    collaborator OTHER

  • Sciotec Diagnostic Technologies GmbH

    collaborator INDUSTRY

  • IPSC AG

    lead INDUSTRY

Principal Investigators

  • Albert Missbichler, PhD · Sciotec Diagnostic Technologies GmbH

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-11-30
Completion
2015-04-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02418221 on ClinicalTrials.gov